Immunotherapy Cancer
Immunotherapy Cancer

Filter

Locations


Result types


Type of company


Industries


Company status

Number of employees

to

Founding year

to


Lock keywords

Exclude keywords

Optional keywords

Clear filters

Products and services for "Immunotherapy Cancer"

Image for CCL21-based immunotherapy for cancer - UNeMed
Product

Verified

CCL21-based immunotherapy for cancer - UNeMed

CCL21 immunotherapy delivers CCL21 directly to the tumor site while protecting it from degradation for a prolonged effect and increased therapeutic impact

by UNeMed Corporation

Image for Cancer Immunotherapy | OncoQR ML
Product

Verified

Cancer Immunotherapy | OncoQR ML

Cancer cells have the ability to escape our immune system´s defenses – by outsmarting checkpoint molecules on our immune cells. Read more

by OncoQR ML GmbH

Image for Immunotherapy of Cancer: Volume 143– Booksmart
Product

Verified

Immunotherapy of Cancer: Volume 143– Booksmart

Immunotherapy of Cancer: Volume 143

by Booksmart

Image for GP2 Cancer Immunotherapy | Greenwich LifeSciences, Inc. (GLSI) | GP2
Product

Verified

GP2 Cancer Immunotherapy | Greenwich LifeSciences, Inc. (GLSI) | GP2

Greenwich LifeScience’s GP2 immunotherapy is a HER2-derived peptide which targets HER2-expressing tumor cells.

by Greenwich LifeSciences

Image for Cancer and Immunotherapy Overview | Greenwich LifeSciences, Inc. (GLSI) | GP2
Product

Verified

Cancer and Immunotherapy Overview | Greenwich LifeSciences, Inc. (GLSI) | GP2

Understand cancer and immunotherapy, cancer’s escape from immunosurveillance, and immune-mechanism distinctions (innate vs. adaptive immunity, helper vs. cytotoxic T cells, antigens vs. antibodies, etc.).

by Greenwich LifeSciences

Image for Cancer Immunotherapy For Pets | Dogwood Veterinary Hospital
Service

Verified

Cancer Immunotherapy For Pets | Dogwood Veterinary Hospital

Like us, pets can get cancer too. But that doesn't mean they're alone. Click to learn about Dogwood Veterinary Hospital's cancer immunotherapy services.

by Dogwood Veterinary Hospital and Laser Center

Image for Cancer Immunotherapy : Immune Suppression and Tumor Growth– Booksmart
Product

Verified

Cancer Immunotherapy : Immune Suppression and Tumor Growth– Booksmart

Cancer Immunotherapy : Immune Suppression and Tumor Growth

by Booksmart

Image for Cancer Immunotherapy Market Growth, Trends, and Forecasts (2020-2026)
Product

Verified

Cancer Immunotherapy Market Growth, Trends, and Forecasts (2020-2026)

The global cancer immunotherapy market was estimated to reach 178.70 billion by 2028. The market is expected to grow at a CAGR of 14.23% from 2020 to 2028.

by Global Monitor

Image for Cancer Immunotherapy
Product

Verified

Cancer Immunotherapy

The immune system's job is to recognise and destroy anything foreign or abnormal in our bodies, including cancer cells. Cancer cells develop when normal cells change into malignant cells.

by Roche Glycart

Image for Cancer immunotherapy
Product

Verified

Cancer immunotherapy

For more than 50 years, Roche has been developing medicines with the goal to redefine treatment in oncology.

by Roche Diagnostics Thailand

187 companies for "Immunotherapy Cancer"

Greenwich LifeSciences's Logo

Stafford, United States

1-10 Employees

2006

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) is a public biopharmaceutical company based in the Houston, TX area that is developing GP2, a novel peptide immunotherapy, and has commenced a Phase III clinical trial, called Flamingo-01. For the 146 patients who have been treated with GP2 immunotherapy to date over 4 clinical trials, treatment was well tolerated and no serious adverse events were observed related to the immunotherapy. One in eight U.S. women will develop invasive breast cancer over her lifetime, with approximately 282,000 new breast cancer patients and 3.8 million breast cancer survivors in 2021, all of whom have the potential to experience breast cancer recurrences. HER2/neu positive breast cancer patients comprise approximately 25% of all breast cancer patients.

+

Featured

Product
Image for Our Cancer Immunotherapy​

Our Cancer Immunotherapy​

... GP2 Cancer Immunotherapy | Greenwich LifeSciences, Inc. (GLSI) | ...

Pelican Therapeutics's Logo

1-10 Employees

2009

The promise of cancer immunotherapy lies in the potential to enhance tumor specific CD8+ cytotoxic T cell responses. Pelican Therapeutics is a clinical stage company within the NightHawk Biosciences ecosystem focused on therapeutic targeting of TNFRSF25 (TNF Receptor Superfamily Member 25) to promote the expansion of effector T cells and maximize the potential of the immune system to mount effective anti-tumor responses. 1305 East Houston StreetSan Antonio, TX 78205, USA.

+

Featured

Core business
Image for Next generation T Cell Immunotherapy for Cancer

Next generation T Cell Immunotherapy for Cancer

... Next generation T Cell Immunotherapy for Cancer ...

Issels Medical Center's Logo

Santa Barbara, United States

1-10 Employees

2007

+

Featured

Core business
Image for Cancer Treatment, Immunotherapy for Cancer, Issels Cancer Immunotherapy, Non-Toxic Cancer Immunotherapy

Cancer Treatment, Immunotherapy for Cancer, Issels Cancer Immunotherapy, Non-Toxic Cancer Immunotherapy

... Cancer Treatment, Immunotherapy for Cancer, Issels Cancer Immunotherapy, Non-Toxic Cancer Immunotherapy ...

OncoQR ML GmbH's Logo

Vienna, Austria

1-10 Employees

2013

We are developing cancer immunotherapies that harness all four natural killing mechanisms of our immune system in a tumor specific manner, which is required to defeat the cancer´s immune evading mechanisms. OncoQR ML is a pre-clinical biotech start-up that offers novel therapeutic cancer vaccines based on its unique, proprietary and broadly applicable…. The S-TIR™technology is an adjustable cancer immunotherapy (ACI) platform that was originally developed by S-TARget therapeutics GmbH for the…. OncoQR ML has achieved in vivo Proof of Concept (PoC) for its two prototype and lead product candidates directed against two major oncology…. Active Checkpoint Control Immunotherapy (ACCI) activates all four naturally available tumor killing mechanisms selectively….

+

Featured

Product
Image for Cancer Immunotherapy

Cancer Immunotherapy

... Cancer Immunotherapy | OncoQR ...

Immutep's Logo

Sydney, Australia

11-50 Employees

2001

Immutep is a clinical-stage biotechnology company at the forefront of developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases. We are pioneers in the understanding and advancement of therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system. Our LAG-3 immunotherapies are distinctly designed to harness and strengthen the power of patients' immune systems to fight cancer and autoimmune disease. Utilizing our LAG-3 expertise, we’re focused on safely delivering on immunotherapy’s promise to drive superior clinical outcomes for patients. We have three clinical-stage & two earlier stage candidates, reflecting our unique ability to harness the LAG-3 immune checkpoint in multiple ways to stimulate or suppress the immune system.

+

Featured

Core business
Image for Immutep | LAG-3 Immunotherapy for Cancer & Autoimmune Disease

Immutep | LAG-3 Immunotherapy for Cancer & Autoimmune Disease

... A Global Leader in LAG-3 Immunotherapy for Cancer and Autoimmune ...

Altevax's Logo

Paris, France

1-10 Employees

2016

LATEST NEWS: Altevax is awarded a 2,4 M€ package by BPI France. Click here to read our press release. Altevax is committed to bringing its innovative anticancer and anti-infectious technology to patients, to treat diseases that have no available cure today. Unlike most current immunotherapies, Altevax technology combines efficiency and specificity. Altevax technology allows to rapidly develop therapies against many diseases, leading to treatments that are easy to produce and administer. CLICK HERE TO SEE HOW THE ALTEVAX TECHNOLOGY WORKS.

+

Featured

Core business
Image for Altevax | A first-in-class immunotherapy against cancer and infectious diseases

Altevax | A first-in-class immunotherapy against cancer and infectious diseases

... Altevax | A first-in-class immunotherapy against cancer and infectious ...

Century Therapeutics's Logo

Philadelphia, United States

101-250 Employees

2018

+

Featured

Core business
Image for Engineering an Evolution in Cancer Immunotherapy

Engineering an Evolution in Cancer Immunotherapy

... Engineering an Evolution in Cancer Immunotherapy ...

Chemedimmune, Inc.'s Logo

Augusta, United States

1-10 Employees

2016

Our mission is to develop Immunotherapeutic agents for treatment of human diseases. Despite the breakthrough of cancer immunotherapy with durable efficacy in many types of human cancers, colorectal and pancreatic cancers do not respond to current immuntherapy. There are therefore unmet need and huge market for new immunotherapuetic agents for colorectal and pancreatic cancers.

+

Featured

Core business
Image for Chemedimmune – Chemedimmune

Chemedimmune – Chemedimmune

... Cancer immunotherapy ...

Asgard Therapeutics's Logo

Lund, Sweden

1-10 Employees

2018

Asgard Therapeutic’s mission is to pioneer direct cell reprogramming for cancer immunotherapy. Our current focus is to develop scalable reprogramming technologies enabling the direct in vivo conversion of cancer cells into professional antigen-presenting dendritic cells, reinstating cancer immunity. In Greek mythology, the Trojan War was fought between the Greeks and Trojans. After 10 years of conflict, the Greeks implemented a strategy based on a hollow wooden horse, the Trojan horse, to enter Troy and win the war from within. According to Norse myths, while the city of Troy was completely devastated, thousands of Trojans left after the war and moved north across Europe.

+

Featured

Core business
Image for Reprogramming is the next leap forward in cancer immunotherapy

Reprogramming is the next leap forward in cancer immunotherapy

... Developing a cancer immunotherapy based on direct cell reprogramming - ASGARD ...

Peter Michael Foundation's Logo

+

Featured

Core business
Image for Immunotherapy Prostate Cancer

Immunotherapy Prostate Cancer

... Immunotherapy Prostate Cancer ...

Show More

„Immunotherapy Cancer“

Immunotherapy cancer is a type of treatment that uses the body's own immune system to fight cancer. It works by helping the immune system recognize and attack cancer cells by boosting the body’s natural defenses. Immunotherapy cancer treatments can be used alone or with other cancer treatments. Immunotherapy cancer treatments are most commonly used to treat melanoma, lung cancer, bladder cancer, and kidney cancer.